PRODUCT PIPELINE

Asthma:
TPI ASM8 - Novel inhaled drug targeting multiple inflammatory cytokine receptors
COPD:
TPI 1020 - New inhaled nitric-oxide form of budesonide inhibiting neutrophils
TPI 1100 - Inhaled inhibitor of multiple PDEs involved in inflammation
Allergic Rhinitis:
TPI ARL8 - Nasal spray targeting multiple inflammatory cytokine receptors